31.03.2014 Views

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

156 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />

❚ other k<strong>in</strong>ases<br />

WNK3<br />

Ref. 2114<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Comprehensive k<strong>in</strong>ase profile<br />

Source<br />

human recomb<strong>in</strong>ant<br />

Substrate ATP + Ulight-ARTKQTARKSTGGKAPRKQLAGCG<br />

(75 nM)<br />

Measured product phospho-Ulight-ARTKQTARKSTGGKAPRKQL<br />

AGCG<br />

Detection method LANCE<br />

Reference<br />

staurospor<strong>in</strong>e (IC 50 : 3.15 µM)<br />

R<strong>in</strong>ehart, J. et al. (2005) Proc. Natl. Acad. Sci. USA, 102: 16777-16782.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

WNK4<br />

Ref. 2633<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Comprehensive k<strong>in</strong>ase profile<br />

Source<br />

human recomb<strong>in</strong>ant<br />

Substrate ATP + Ulight-ARTKQTARKSTGGKAPRKQLAGCG<br />

(25 nM)<br />

Measured product phospho-Ulight-ARTKQTARKSTGGKAPRKQL<br />

AGCG<br />

Detection method LANCE<br />

Reference<br />

staurospor<strong>in</strong>e (IC 50 : 235 nM)<br />

Vitari, A.C. et al. (2005) Biochem. J., 391: 17-24.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

❚ atypical k<strong>in</strong>ases<br />

<br />

<br />

<br />

<br />

<br />

<br />

mTOR k<strong>in</strong>ase (FRAP1)<br />

Ref. 2941<br />

Q 3 weeks<br />

Source<br />

human recomb<strong>in</strong>ant (<strong>in</strong>sect cells)<br />

Substrate ATP + Ulight-FLGFTYVAP<br />

(40 nM)<br />

Measured product phospho-Ulight-FLGFTYVAP<br />

Detection method LANCE<br />

Reference<br />

PI-103 (IC 50 : 129 nM)<br />

Aoki, M. et al. (2001) Proc. Natl. Acad. Sci. USA, 98: 136-141.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

For further details and updated <strong>in</strong>formation on assays:<br />

❚ Please go to www.cerep.com catalog onl<strong>in</strong>e or contact us at sales@cerep.com<br />

❚ Europe: +33 (0)5 49 89 30 00 – USA: +1 (425) 895 8666 – Japan: +81 (0)3 3354 4026 – Ch<strong>in</strong>a: +86 21 5132 0568<br />

Assay developed <strong>in</strong> 2010 New assay conditions and/or assay converted from HTRF ® to LANCEUltra ®<br />

Human Q Standard turnaround time

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!